Metraipolis › archive › dc_ea1240e227b0
Design Considerations for a Phase II Platform Trial in Major Depressive Disorder — Europe PMC PMID:40864526
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40864526
- DOI
- 10.1002/pst.70025
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T05:02:44.030Z
- SHA-256 of the archived text
eab3b3c58e91842cce3d28995ab1785905e0ef7da17bcdbc9048ee4772f15b1f- Stable URL of this page
https://metraipolis.com/documento/dc_ea1240e227b0
How to cite
Design Considerations for a Phase II Platform Trial in Major Depressive Disorder — Europe PMC PMID:40864526 — Europe PMC (en), https://europepmc.org/article/MED/40864526 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ea1240e227b0 (Metraipolis archive dc_ea1240e227b0, sha256 eab3b3c58e91842cce3d28995ab1785905e0ef7da17bcdbc9048ee4772f15b1f)
BibTeX
@misc{dcea1240e227b0,
title = {Design Considerations for a Phase II Platform Trial in Major Depressive Disorder — Europe PMC PMID:40864526},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40864526},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ea1240e227b0; sha256 eab3b3c58e91842cce3d28995ab1785905e0ef7da17bcdbc9048ee4772f15b1f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40864526. Agents can read the archived copy with the MCP tool read_document.